Correlation Between DiaMedica Therapeutics and Foghorn Therapeutics

Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DiaMedica Therapeutics and Foghorn Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Foghorn Therapeutics.

Diversification Opportunities for DiaMedica Therapeutics and Foghorn Therapeutics

-0.38

Correlation Coefficient

DiaMedica Therapeutics  Foghorn Therapeutics

Very good diversification

The 3 months correlation between DiaMedica and Foghorn is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Foghorn Therapeutics go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Foghorn Therapeutics

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.38 times less return on investment than Foghorn Therapeutics. But when comparing it to its historical volatility, DiaMedica Therapeutics is 2.27 times less risky than Foghorn Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  419.00  in Foghorn Therapeutics on December 2, 2024 and sell it today you would earn a total of  66.00  from holding Foghorn Therapeutics or generate 15.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

DiaMedica Therapeutics  vs.  Foghorn Therapeutics

DiaMedica Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Foghorn Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Foghorn Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with DiaMedica Therapeutics and Foghorn Therapeutics

The main advantage of trading using opposite DiaMedica Therapeutics and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.

The idea behind DiaMedica Therapeutics and Foghorn Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.